Same Indication

Buprenorphine vs Inotuzumab Ozogamicin

## Buprenorphine vs Inotuzumab Ozogamicin: Overview

This comparison examines the pharmacological differences between **Buprenorphine** and **Inotuzumab Ozogamicin**.

## Mechanism of Action

**Buprenorphine**: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

## Pharmacokinetics

**Half-life**: Buprenorphine — 24-42 hours; Inotuzumab Ozogamicin — N/A.

## Chemical Properties

**Molecular Formula**: Buprenorphine — C29H41NO4; Inotuzumab Ozogamicin — N/A.

**Molecular Weight**: Buprenorphine — 467.6430 g/mol; Inotuzumab Ozogamicin — N/A.

**Type**: Buprenorphine — Small molecule; Inotuzumab Ozogamicin — Antibody drug conjugate.